Advances in Transdermal Drug Delivery for Cancer Therapy
Abstract
Transdermal drug delivery offers a promising alternative to traditional cancer therapies by providing a non-invasive, controlled, and targeted delivery of therapeutic agents. This paper explores the advancements, benefits, and challenges associated with transdermal drug delivery systems (TDDS) in cancer treatment. It highlights the mechanisms of action, key technologies, and the potential impact on patient outcomes. By examining recent studies and clinical trials, this paper aims to provide a comprehensive overview of the efficacy, safety, and prospects of transdermal drug delivery in oncology.
References
Pena-Juarez MC, Guadarrama-Escobar OR, Escobar-Chavez JJ, 2021, Transdermal Delivery Systems for Biomolecules. Journal of Pharmaceutical Innovation, (17): 319–332.
Saindane D, Bhattacharya S, Shah R, et al., 2022, The Recent Development of Topical Nanoparticles for Annihilating Skin Cancer. All Life, 15(1): 843–869.
Escobar-Chavez JJ, Diaz-Torres R, Rodriguez-Cruz IM, et al., 2012, Nanocarriers for Transdermal Drug Delivery. Research and Reports in Transdermal Drug Delivery, (2012): 3–17.
Bird D, Ravindra NM, 2020, Transdermal Drug Delivery and Patches—An Overview. Medical Devices & Sensors, 3(6): e10069.
Chen M, Quan G, Sun Y, et al., 2020, Nanoparticles-Encapsulated Polymeric Microneedles for Transdermal Drug Delivery. Journal of Controlled Release, (325): 163–175.
Anirudhan TS, Nair AS, Bino SJ, 2017, Nanoparticle Assisted Solvent Selective Transdermal Combination Therapy of Curcumin and 5-Flurouracil for Efficient Cancer Treatment. Carbohydrate polymers, (173): 131–142.
Lorscheider M, Gaudin A, Nakhle J, et al., 2021, Challenges and Opportunities in the Delivery of Cancer Therapeutics: Update on Recent Progress. Therapeutic Delivery, 12(1): 55–76.
Amani H, Shahbazi MA, D’Amico C, et al., 2021, Microneedles for Painless Transdermal Immunotherapeutic Applications. Journal of Controlled Release, (330): 185–217.
Zhang LK, Du S, Wang X, et al., 2019, Bacterial Cellulose Based Composites Enhanced Transdermal Drug Targeting for Breast Cancer Treatment. Chemical Engineering Journal, (370): 749–759.
Petrilli R, Eloy JO, Saggioro FP, et al., 2018, Skin Cancer Treatment Effectiveness Is Improved by Iontophoresis of EGFR-Targeted Liposomes Containing 5-FU Compared with Subcutaneous Injection. Journal of controlled release, (283): 151–162.
Qindeel M, Ullah MH, Ahmed N, 2020, Recent Trends, Challenges and Future Outlook of Transdermal Drug Delivery Systems for Rheumatoid Arthritis Therapy. Journal of Controlled Release, (327): 595–615.
Ahmed KS, Shan X, Mao J, et al., 2019, Derma Roller® Microneedles-Mediated Transdermal Delivery of Doxorubicin and Celecoxib Co-Loaded Liposomes for Enhancing the Anticancer Effect. Mater Sci Eng C Mater Biol Appl, (99): 1448–1458.
